CA3223354A1 - Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof - Google Patents
Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof Download PDFInfo
- Publication number
- CA3223354A1 CA3223354A1 CA3223354A CA3223354A CA3223354A1 CA 3223354 A1 CA3223354 A1 CA 3223354A1 CA 3223354 A CA3223354 A CA 3223354A CA 3223354 A CA3223354 A CA 3223354A CA 3223354 A1 CA3223354 A1 CA 3223354A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- group
- compound
- compound represented
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-108230 | 2021-06-30 | ||
| JP2021108230 | 2021-06-30 | ||
| PCT/JP2022/026168 WO2023277120A1 (ja) | 2021-06-30 | 2022-06-30 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3223354A1 true CA3223354A1 (en) | 2023-01-05 |
Family
ID=84691891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3223354A Pending CA3223354A1 (en) | 2021-06-30 | 2022-06-30 | Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240309010A1 (https=) |
| EP (1) | EP4365174A4 (https=) |
| JP (2) | JP7476431B2 (https=) |
| KR (1) | KR20240027603A (https=) |
| CN (2) | CN121873082A (https=) |
| AR (1) | AR126290A1 (https=) |
| AU (1) | AU2022300611A1 (https=) |
| BR (1) | BR112023025934A2 (https=) |
| CA (1) | CA3223354A1 (https=) |
| IL (1) | IL309736A (https=) |
| MX (1) | MX2023014123A (https=) |
| WO (1) | WO2023277120A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9890142B2 (en) * | 2013-07-10 | 2018-02-13 | Meiji Seika Pharma Co., Ltd. | PDE4 inhibitor |
| MX389276B (es) * | 2016-12-26 | 2025-03-20 | Meiji Seika Pharma Co Ltd | Compuesto novedoso y sal de este aceptable desde el punto de vista farmacologico. |
| KR102931303B1 (ko) * | 2018-06-27 | 2026-02-25 | 메이지 세이카 파루마 가부시키가이샤 | 염증성 질환, 자가면역 질환, 섬유화 질환 및 암 질환의 치료제 |
| JP2021155336A (ja) * | 2018-06-27 | 2021-10-07 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
-
2022
- 2022-06-30 MX MX2023014123A patent/MX2023014123A/es unknown
- 2022-06-30 JP JP2023532045A patent/JP7476431B2/ja active Active
- 2022-06-30 CN CN202610020318.9A patent/CN121873082A/zh active Pending
- 2022-06-30 IL IL309736A patent/IL309736A/en unknown
- 2022-06-30 CA CA3223354A patent/CA3223354A1/en active Pending
- 2022-06-30 KR KR1020237043708A patent/KR20240027603A/ko active Pending
- 2022-06-30 WO PCT/JP2022/026168 patent/WO2023277120A1/ja not_active Ceased
- 2022-06-30 EP EP22833266.4A patent/EP4365174A4/en active Pending
- 2022-06-30 BR BR112023025934A patent/BR112023025934A2/pt unknown
- 2022-06-30 AU AU2022300611A patent/AU2022300611A1/en active Pending
- 2022-06-30 AR ARP220101722A patent/AR126290A1/es unknown
- 2022-06-30 US US18/575,158 patent/US20240309010A1/en active Pending
- 2022-06-30 CN CN202280035356.1A patent/CN117295744A/zh active Pending
-
2024
- 2024-04-17 JP JP2024067062A patent/JP7839217B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7839217B2 (ja) | 2026-04-01 |
| CN117295744A (zh) | 2023-12-26 |
| EP4365174A4 (en) | 2025-07-02 |
| US20240309010A1 (en) | 2024-09-19 |
| KR20240027603A (ko) | 2024-03-04 |
| MX2023014123A (es) | 2023-12-12 |
| BR112023025934A2 (pt) | 2024-02-27 |
| JP7476431B2 (ja) | 2024-04-30 |
| EP4365174A1 (en) | 2024-05-08 |
| AU2022300611A1 (en) | 2024-01-25 |
| WO2023277120A1 (ja) | 2023-01-05 |
| CN121873082A (zh) | 2026-04-17 |
| AR126290A1 (es) | 2023-10-04 |
| TW202311242A (zh) | 2023-03-16 |
| JP2024096941A (ja) | 2024-07-17 |
| JPWO2023277120A1 (https=) | 2023-01-05 |
| IL309736A (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024202049A1 (en) | Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection | |
| AU2018337597B2 (en) | Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7- yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives | |
| US11040953B2 (en) | Process for the preparation of a diarylthiohydantoin compound | |
| KR102396059B1 (ko) | 신규 화합물 및 이의 제조방법 | |
| KR102230628B1 (ko) | 보르티옥세틴 제조 방법 | |
| CN116987112B (zh) | 制备氨基嘧啶衍生物的改善方法 | |
| AU2018308039A1 (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
| CA3107270A1 (en) | Method for producing tetracyclic compound | |
| CA3223354A1 (en) | Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof | |
| KR102513869B1 (ko) | (시클로펜틸[d]피리미딘-4-일)피페라진 화합물의 제조 방법 | |
| RU2858377C2 (ru) | Способ получения производного бензоксазола, содержащего бициклическое пиперазиновое кольцо, или его соли и способ получения исходного вещества для него | |
| FI83643C (fi) | Foerfarande foer framstaellning av dihydrokinolinkarboxylsyror. | |
| US20120071662A1 (en) | Preparing aminoarylalkyl compounds | |
| US6313292B1 (en) | Process for preparing 4,6-disubstituted pyrido[3,4-d]pyrimidines | |
| TWI915570B (zh) | 具有二環性哌嗪環之苯并噁唑衍生物或其鹽之製造方法以及其原料之製造方法 | |
| JP6368043B2 (ja) | 三環式ラクタム化合物の製造法 | |
| EP4628491A1 (en) | Synthesis of intermediates for the preparation of neurokinin-3 receptor antagonists | |
| EP0831081B1 (en) | Production of aminophenols | |
| EP0131921B1 (en) | Ortho-(mono-substituted amino)phenylimines and production thereof | |
| JPWO2004103979A1 (ja) | Ｎ−（２−アミノ−４，６−ジクロロピリミジン−５−イル）ホルムアミドの製造方法 | |
| Ryabova et al. | Transformations of ortho-methoxyaryl (hetaryl) carboxamides into quinazolin-4-one and pyrido [2, 3-d] pyrimidin-4-one derivatives | |
| Kuehn et al. | A facile access to indigodianiles | |
| Cho | Direct and Modular Access to Functionalized Arenes and Cyclohexenes Mediated by Deprotonative C–H Zincation | |
| Nishiwaki et al. | A new approach to 6-nitro-1H-[1, 4]-diazepines | |
| Bobrov et al. | Unusual scission of 3, 7-dichlorobisisothiazolo [4, 5-b: 4", 5"-e] pyrazine by nucleophiles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250618 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250618 |